NOVEL TYROSINE KINASE INHIBITORS

A compound represented by formula (I) or a stereoisomer, tautomer, salt, or hydrate thereof: for use as a medicament, in particular for use in treating, preventing, or inhibiting a condition or disorder related to tyrosine kinase TrkA activity such as chronic pain, an inflammatory disease, or a hype...

Full description

Saved in:
Bibliographic Details
Main Authors MIKEL, CHARLES, GREGOR, VLAD, EDWARD, YAN, ZHENG, LIU, YAHUA, ZOZULYA, SERGEY, ZHU, TONG, KADUSHKIN, ALEXANDER, VAIRAGOUNDAR, RANENDRAN, MCGRATH, DOUGLAS, ERIC, JIANG, LUYONG, VAVILALA, GOVERDHAN, REDDY, ANIKIN, ALEXEY, THIRUVAZHI, MOHAN, SANTHANAM, CHUCHOLOWSKI, ALEXANDER, KHASANOV, ALISHER, PICKENS, JASON, C
Format Patent
LanguageEnglish
French
German
Published 12.08.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A compound represented by formula (I) or a stereoisomer, tautomer, salt, or hydrate thereof: for use as a medicament, in particular for use in treating, preventing, or inhibiting a condition or disorder related to tyrosine kinase TrkA activity such as chronic pain, an inflammatory disease, or a hyperproliferative skin disease.
Bibliography:Application Number: EP20090721981